Renibus Therapeutics to present at Oppenheimer life sciences showcase Sept. 29

Verifying
  • Renibus Therapeutics will participate in the Oppenheimer Private Life Sciences Showcase on September 29, 2026.
  • Bhupinder Singh will present virtually at 11:15 a.m. Eastern Standard Time.
  • RBT-1 completed the PROTECT Phase 3 trial in cardiac-surgery patients.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.